Literature DB >> 18273045

BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias.

J Davidsson, H Lilljebjörn, I Panagopoulos, T Fioretos, B Johansson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18273045     DOI： 10.1038/leu.2008.14

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  BRAF mutations in hairy-cell leukemia.

Authors:  Enrico Tiacci; Vladimir Trifonov; Gianluca Schiavoni; Antony Holmes; Wolfgang Kern; Maria Paola Martelli; Alessandra Pucciarini; Barbara Bigerna; Roberta Pacini; Victoria A Wells; Paolo Sportoletti; Valentina Pettirossi; Roberta Mannucci; Oliver Elliott; Arcangelo Liso; Achille Ambrosetti; Alessandro Pulsoni; Francesco Forconi; Livio Trentin; Gianpietro Semenzato; Giorgio Inghirami; Monia Capponi; Francesco Di Raimondo; Caterina Patti; Luca Arcaini; Pellegrino Musto; Stefano Pileri; Claudia Haferlach; Susanne Schnittger; Giovanni Pizzolo; Robin Foà; Laurent Farinelli; Torsten Haferlach; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  N Engl J Med       Date:  2011-06-11       Impact factor: 91.245

2.  B-Raf regulation of integrin α4β1-mediated resistance to shear stress through changes in cell spreading and cytoskeletal association in T cells.

Authors:  Wells S Brown; Jahan S Khalili; Tania G Rodriguez-Cruz; Greg Lizee; Bradley W McIntyre
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

3.  BRAF V600E and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone lymphoma cases.

Authors:  Sang-Yong Shin; Seung-Tae Lee; Hee-Jin Kim; Chang-Seok Ki; Chul Won Jung; Jong-Won Kim; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2015-02-12       Impact factor: 3.464

4.  Genetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAFV600E mutations in adult populations.

Authors:  Joanne Louise Selway; Parvathy Elacode Harikumar; Anthony Chu; Kenneth Langlands
Journal:  Oncol Lett       Date:  2017-08-18       Impact factor: 2.967

Review 5.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

6.  RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures.

Authors:  Francianne Gomes Andrade; Juliana Montibeller Furtado-Silva; Bruno Alves de Aguiar Gonçalves; Luiz Claudio Santos Thuler; Thayana Conceição Barbosa; Mariana Emerenciano; André Siqueira; Maria S Pombo-de-Oliveira
Journal:  BMC Cancer       Date:  2014-02-26       Impact factor: 4.430

Review 7.  Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and Its Therapeutic Targeting.

Authors:  Thomas Knight; Julie Anne Elizabeth Irving
Journal:  Front Oncol       Date:  2014-06-24       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.